HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Abstract Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Wong, S. N. Articles by Lin, S.-M. Search for Related Content PubMed PubMed Citation Articles by Wong, S. N. Articles by Lin, S.-M. Social Bookmarking                      What's this? Hotlight (NEW!) What's Hotlight?

Combined Percutaneous Radiofrequency Ablation and Ethanol Injection for Hepatocellular Carcinoma in High-Risk Locations

¹ Liver Research Unit, Department of Hepatogastroenterology, Chang Gung Memorial Hospital and Chang Gung University, 199, Tunghwa Rd., Taipei, Taiwan.
² Section of Gastroenterology, University of Santo Tomas Hospital, Manila, Philippines.

View larger version (15K): [in this window] [in a new window] [as a PowerPoint slide]   Fig. 1 —Schematic shows patient and tumor distribution in analyses of outcomes. TACE = transarterial chemoembolization, HR = high risk, PEI = percutaneous ethanol injection.

View larger version (13K): [in this window] [in a new window] [as a PowerPoint slide]   Fig. 2 —Distribution of high-risk tumors. * = 44 tumors were located near both vessel/s and vital structure. PV = portal vein, HV = hepatic vein, IVC = inferior vena cava, GB = gallbladder, GIT = gastrointestinal tract.

View larger version (15K): [in this window] [in a new window] [as a PowerPoint slide]   Fig. 3 —Graph compares local tumor progression rates for three treatment groups. HR = high-risk, RF = radiofrequency, NHR = non-high-risk, PEI = percutaneous ethanol injection.

View larger version (116K): [in this window] [in a new window] [as a PowerPoint slide]   Fig. 4A —45-year-old man with hepatitis B virus–related cirrhosis and hepatocellular carcinoma. Indistinct tumor border is independent predictor of local tumor progression. Arterial phase CT scan before radiofrequency ablation shows enhancement of solitary tumor (arrows) at segment VII.

View larger version (123K): [in this window] [in a new window] [as a PowerPoint slide]   Fig. 4B —45-year-old man with hepatitis B virus–related cirrhosis and hepatocellular carcinoma. Indistinct tumor border is independent predictor of local tumor progression. Portal phase CT scan before radiofrequency ablation shows contrast washout (arrows) at segment VII.

View larger version (134K): [in this window] [in a new window] [as a PowerPoint slide]   Fig. 4C —45-year-old man with hepatitis B virus–related cirrhosis and hepatocellular carcinoma. Indistinct tumor border is independent predictor of local tumor progression. Sonographic image shows indistinct tumor borders (arrows), as in A and B.

View larger version (127K): [in this window] [in a new window] [as a PowerPoint slide]   Fig. 4D —45-year-old man with hepatitis B virus–related cirrhosis and hepatocellular carcinoma. Indistinct tumor border is independent predictor of local tumor progression. Dynamic CT scan 1 day after radiofrequency ablation shows complete ablation of area of index tumor with peripheral enhancement due to postablation hyperemia.

View larger version (126K): [in this window] [in a new window] [as a PowerPoint slide]   Fig. 4E —45-year-old man with hepatitis B virus–related cirrhosis and hepatocellular carcinoma. Indistinct tumor border is independent predictor of local tumor progression. Repeated CT scans 2 months after D show local tumor progression at posterior border of ablation zone with enhancement (arrowhead) in arterial (E) and washout in portal (F) phases.

View larger version (121K): [in this window] [in a new window] [as a PowerPoint slide]   Fig. 4F —45-year-old man with hepatitis B virus–related cirrhosis and hepatocellular carcinoma. Indistinct tumor border is independent predictor of local tumor progression. Repeated CT scans 2 months after D show local tumor progression at posterior border of ablation zone with enhancement (arrowhead) in arterial (E) and washout in portal (F) phases.

View larger version (9K): [in this window] [in a new window] [as a PowerPoint slide]   Fig. 5 —Graphs compare survival (left) and local tumor progression-free survival (right) rates for patient groups. HR = high-risk, NHR = non-high-risk.

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati